Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bio-Techne (TECH) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Bio-Techne (TECH) over the last 17 years, with Q4 2025 value amounting to $38.0 million.

  • Bio-Techne's Consolidated Net Income rose 893.95% to $38.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $30.0 million, marking a year-over-year decrease of 7461.18%. This contributed to the annual value of $22.2 million for FY2025, which is 8261.11% down from last year.
  • Bio-Techne's Consolidated Net Income amounted to $38.0 million in Q4 2025, which was up 893.95% from $38.2 million recorded in Q3 2025.
  • Bio-Techne's 5-year Consolidated Net Income high stood at $89.7 million for Q3 2022, and its period low was -$68.8 million during Q2 2025.
  • Its 5-year average for Consolidated Net Income is $38.9 million, with a median of $45.5 million in 2021.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first surged by 56312.36% in 2022, then tumbled by 1621943.79% in 2025.
  • Over the past 5 years, Bio-Techne's Consolidated Net Income (Quarter) stood at $72.1 million in 2021, then crashed by 30.61% to $50.0 million in 2022, then crashed by 45.08% to $27.5 million in 2023, then grew by 27.03% to $34.9 million in 2024, then increased by 8.94% to $38.0 million in 2025.
  • Its last three reported values are $38.0 million in Q4 2025, $38.2 million for Q3 2025, and -$68.8 million during Q2 2025.